Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

NCT01499953 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

472

Enrollment

OTHER

Sponsor class

Conditions

Superficial Vein Thrombosis

Interventions

DRUG: Rivaroxaban
DRUG: Fondaparinux

Sponsor

GWT-TUD GmbH

Collaborators

[object Object]